CollPlant Biotechnologies (NASDAQ:CLGN), a regenerative and aesthetic medicine company developing innovative technologies and products for tissue regeneration and organ manufacturing, today announced the
Northland Capital Markets analyst Tim Savageaux upgrades Casa Systems (NASDAQ:CASA) from Market Perform to Outperform and raises the price target from $6 to $10.
Barclays analyst Matthew Bouley lowered Latham Group Inc’s (NASDAQ:SWIM) price target to $23 (implying an upside of 75%) from $37 and maintained an Overweight rating…